Enantiomers Novelty Protection and its Influence on Generic Market: An Example with Escitalopram Patent Protection-Reference-Cited by-同舟云学术

Enantiomers Novelty Protection and its Influence on Generic Market: An Example with Escitalopram Patent Protection

Published:2013-01 Issue:4 Volume:27 Page:4044-4047
ISSN:1310-2818
Container-title:Biotechnology & Biotechnological Equipment
language:en
Short-container-title:Biotechnology & Biotechnological Equipment

Author:

Peikova Lily,Manova Manoela,Georgieva Svetla,Petrova Guenka

Publisher

Informa UK Limited

Subject

Biotechnology

Link

http://www.tandfonline.com/doi/pdf/10.5504/BBEQ.2013.0048

Reference31 articles.

1. Putting chirality to work: the strategy of chiral switches

2. Bareket E. (2009) Escitalopram: an application for SPC refused due to previous registration of the racemic drug, Israeli IP newsletter, Reinhold Cohn Group

3. Medicamentos Quirais: da dimensão química à discussão política

4. A Double-Blind Comparison of Escitalopram and Venlafaxine Extended Release in the Treatment of Major Depressive Disorder

5. Bongers F., Garradinha H. (2009) European Medicines Association

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Opportunities and Challenges in Mechanochemical Cocrystallization toward Scaled-Up Pharmaceutical Manufacturing;Organic Process Research & Development;2023-02-13

2. HPLC determination of Escitalopram in tablet dosage forms;Pharmacia;2022-01-05

3. Insight into Concept and Progress on Pharmaceutical Co-Crystals: An overview;Indian Journal of Pharmaceutical Education and Research;2019-11-11

4. Pharmaceutical cocrystals: from serendipity to design to application;Drug Discovery Today;2019-03

5. Theobromine cocrystals with monohydroxybenzoic acids – synthesis, X-ray structural analysis, solubility and thermal properties;CrystEngComm;2019